Literature DB >> 19356263

Hospital admission for non-fatal poisoning with weak analgesics and risk for subsequent suicide: a population study.

P Qin1, P Jepsen, B Nørgård, E Agerbo, P B Mortensen, H Vilstrup, H T Sørensen.   

Abstract

BACKGROUND: Poisoning with weak analgesics is a major public health problem because of easy accessibility of the compounds; however, few studies have investigated their influence on subsequent suicide in the context of subjects' psychiatric status and other factors.
METHOD: This nested case-control study was based on the entire Danish population including all 21,169 suicide cases and 423,128 matched population controls. Data on hospital admissions for poisoning and confounding factors were retrieved from national medical and administrative registries. Conditional logistic regression was used to compute relative risk.
RESULTS: A prior hospital admission for poisoning with weak non-opioid analgesics significantly increased the risk of subsequent suicide [crude incidence rate ratio (IRR) 24.7, 95% confidence interval (CI) 22.1-27.6], and the effect of paracetamol poisoning was substantially stronger than that of poisoning with salicylates or non-steroidal anti-inflammatory drugs (NSAIDs). This association could not be explained by confounding from socio-economic or psychiatric factors. The elevated risk was extremely high during the first week following the overdose (adjusted IRR 738.9, 95% CI 173.9-3139.1), then declined over time but still remained significantly high 3 years later (adjusted IRR 4.2, 95% CI 3.5-5.0). Moreover, a history of weak analgesic poisoning significantly interacted with a person's psychiatric history, increasing the risk for subsequent suicide substantially more for persons with no history of psychiatric hospitalization than did it for those with such a history.
CONCLUSIONS: A history of non-fatal poisoning with weak analgesics is a strong predictor for subsequent suicide. These results emphasize the importance of intensive psychiatric care of patients following overdose.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19356263     DOI: 10.1017/S0033291709005741

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  7 in total

1.  Examining the role of extracorporeal membrane oxygenation in patients following suspected or confirmed suicide attempts: A case series.

Authors:  Adeel Abbasi; Cynthia Devers; Christopher S Muratore; Colin Harrington; Corey E Ventetuolo
Journal:  J Crit Care       Date:  2017-10-18       Impact factor: 3.425

2.  Deliberate self-harm before psychiatric admission and risk of suicide: survival in a Danish national cohort.

Authors:  Trine Madsen; Esben Agerbo; Preben B Mortensen; Merete Nordentoft
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-04-23       Impact factor: 4.328

Review 3.  Preventing suicide among inpatients.

Authors:  Isaac Sakinofsky
Journal:  Can J Psychiatry       Date:  2014-03       Impact factor: 4.356

4.  Plasma and liver acetaminophen-protein adduct levels in mice after acetaminophen treatment: dose-response, mechanisms, and clinical implications.

Authors:  Mitchell R McGill; Margitta Lebofsky; Hye-Ryun K Norris; Matthew H Slawson; Mary Lynn Bajt; Yuchao Xie; C David Williams; Diana G Wilkins; Douglas E Rollins; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2013-04-06       Impact factor: 4.219

5.  Children at Risk for Suicide Attempt and Attempt-related Injuries: Findings from the 2007 Youth Risk Behavior Survey.

Authors:  Bethany A West; Monica H Swahn; Frances McCarty
Journal:  West J Emerg Med       Date:  2010-08

6.  Analyses of Child and Youth Self-Poisoning Hospitalizations by Substance and Socioeconomic Status.

Authors:  Samantha Pawer; Fahra Rajabali; Alex Zheng; Jennifer Smith; Roy Purssell; Ian Pike
Journal:  Int J Environ Res Public Health       Date:  2021-06-30       Impact factor: 3.390

7.  Effect of assertive outreach after suicide attempt in the AID (assertive intervention for deliberate self harm) trial: randomised controlled trial.

Authors:  Britt Morthorst; Jesper Krogh; Annette Erlangsen; Francisco Alberdi; Merete Nordentoft
Journal:  BMJ       Date:  2012-08-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.